Our Pricing

What Is the Best Antidepressant for Weight Loss?

Understanding what is the best antidepressant for weight loss is essential for UK patients managing both depression and weight concerns. While most antidepressants are associated with weight gain, certain medications—particularly bupropion (not routinely available on NHS)—may cause modest weight loss in some patients. At Cured Pharmacy, our UK-registered clinical team can assess whether depression medication or dedicated weight loss treatments are appropriate for your individual circumstances.

What Is the Best Antidepressant for Weight Loss: Understanding the Evidence

When considering what is the best antidepressant for weight loss, it's important to understand that antidepressants are primarily licensed to treat depression, anxiety, and related mental health conditions—not for weight management [1]. However, certain antidepressants have different metabolic profiles that may influence body weight.

Bupropion (marketed as Wellbutrin in some countries) is the antidepressant most consistently associated with weight loss in clinical trials, with patients experiencing an average reduction of 2-3kg over 6-12 months compared to placebo [1][2]. This medication works by inhibiting the reuptake of dopamine and noradrenaline, which may suppress appetite and increase energy expenditure.

In the UK, bupropion is licensed under the brand name Zyban for smoking cessation, but it is not routinely prescribed by the NHS for depression or weight loss. Some private psychiatrists may prescribe it off-label for depression, subject to clinical assessment and prescriber discretion [3].

Antidepressants and Weight: What UK Patients Need to Know

Most commonly prescribed antidepressants in the UK—including selective serotonin reuptake inhibitors (SSRIs) like sertraline, citalopram, and fluoxetine—are associated with modest weight gain over time, typically 1-5kg over several months of treatment [2][4]. This occurs through increased appetite, altered metabolism, and changes in food preferences.

Fluoxetine (Prozac) is sometimes considered the most weight-neutral SSRI, with some patients experiencing slight weight loss during initial treatment, though this effect typically diminishes after 6 months [2]. Sertraline and escitalopram show similar weight-neutral profiles in short-term studies but may contribute to gradual weight gain with long-term use.

Mirtazapine and tricyclic antidepressants like amitriptyline are among the antidepressants most strongly associated with weight gain, with patients gaining an average of 3-7kg within the first year of treatment [4]. These medications increase appetite through antihistamine effects and metabolic changes.

Why Antidepressants Affect Weight Differently

Different antidepressants interact with distinct neurotransmitter systems, which explains their varying effects on appetite and metabolism. Medications that block histamine H1 receptors (like mirtazapine) tend to increase appetite and cause sedation, whilst those affecting dopamine and noradrenaline (like bupropion) may suppress appetite and increase energy levels [1][2].

Individual responses vary significantly based on genetics, baseline metabolism, lifestyle factors, and concurrent medications. What causes weight loss in one patient may have no effect or cause weight gain in another, making personalised clinical assessment essential.

Licensed Weight Loss Treatments vs Antidepressants

For UK patients whose primary concern is weight management rather than depression, dedicated weight loss medications offer significantly greater efficacy than any antidepressant. GLP-1 receptor agonists like semaglutide (Wegovy) and tirzepatide (Mounjaro) produce average weight reductions of 15-22.5% of total body weight in clinical trials—far exceeding the 2-3kg loss seen with bupropion [5][6].

At Cured Pharmacy, we offer several MHRA-licensed weight loss treatments from £135.00 all requiring clinical assessment by a UK prescriber. Mounjaro (tirzepatide) is available from £135.00 and represents the most effective weight loss medication currently available, whilst Wegovy (semaglutide) starts from £135.00 and offers proven efficacy with once-weekly dosing.

For patients managing both depression and weight concerns, your prescriber may recommend treating each condition separately with appropriate medications rather than relying on an antidepressant's weight effects. This approach typically produces better outcomes for both mental health and weight management [3][4].

How GLP-1 Medications Work

GLP-1 receptor agonists like Wegovy and Mounjaro work by mimicking natural hormones that regulate appetite, blood sugar, and digestion. These medications slow gastric emptying, reduce hunger signals in the brain, and improve insulin sensitivity, leading to sustained weight loss when combined with lifestyle modifications [5][6].

Unlike the modest weight effects of antidepressants, GLP-1 treatments are specifically licensed for chronic weight management in adults with a BMI of 30 or above (or 27 with weight-related health conditions). All prescriptions require ongoing monitoring by a UK healthcare professional.

Bupropion and Naltrexone Combination: Mysimba

Mysimba is a licensed weight loss medication available in the UK that combines bupropion with naltrexone, an opioid receptor antagonist. This combination works on brain pathways that regulate appetite and reward, producing greater weight loss than bupropion alone—typically 5-10% of total body weight over 56 weeks in clinical trials [7].

Whilst Mysimba contains the antidepressant bupropion, it is not licensed or prescribed for depression. The medication is specifically indicated for weight management in adults with a BMI of 30 or above (or 27 with weight-related conditions) as part of a comprehensive weight management programme including diet and exercise [7].

Mysimba requires gradual dose escalation over four weeks to minimise side effects such as nausea, headache, and constipation. Patients with uncontrolled hypertension, seizure disorders, or eating disorders cannot take this medication, making thorough clinical assessment essential before prescribing.

What Is the Best Antidepressant for Weight Loss: Clinical Considerations

When a UK prescriber considers what is the best antidepressant for weight loss for an individual patient, the primary consideration is always treating the underlying mental health condition effectively. Weight effects are secondary to therapeutic efficacy, tolerability, and safety profile [3][4].

If you're currently taking an antidepressant and experiencing unwanted weight gain, speak to your GP or psychiatrist before making any changes. Abruptly stopping antidepressants can cause withdrawal symptoms and mental health deterioration. Your prescriber may suggest switching to a more weight-neutral option like fluoxetine or sertraline, or addressing weight management separately [4].

For patients without depression seeking weight loss, antidepressants should never be prescribed solely for weight management. Dedicated weight loss treatments like Orlistat (from £135.00), Saxenda (from £135.00), Wegovy (from £135.00), or Mounjaro (from £135.00) offer superior efficacy with appropriate safety profiles when prescribed by UK clinicians following thorough assessment.

Important Safety Considerations

All antidepressants and weight loss medications carry potential side effects and contraindications that must be carefully evaluated. Bupropion, for example, lowers the seizure threshold and cannot be used in patients with epilepsy, eating disorders, or those undergoing alcohol or benzodiazepine withdrawal [1][3].

Combining antidepressants with weight loss medications requires careful monitoring for drug interactions and cumulative side effects. Your UK prescriber will review your complete medication history, including over-the-counter products and supplements, before recommending any treatment plan.

Getting Started with Weight Loss Treatment at Cured Pharmacy

At Cured Pharmacy, our UK-registered clinical team (led by Superintendent Pharmacist Tarun Kumar, GPhC 2233073) provides comprehensive weight loss assessments in under 3 minutes through our secure online consultation platform. We offer transparent upfront pricing with no hidden fees—you'll see exact costs before completing your clinical assessment.

Our weight loss treatments include Mounjaro (from £135.00), Wegovy (from £135.00), Saxenda (from £135.00), and Orlistat (from £135.00), all requiring clinical approval by a UK prescriber. Every medication is sourced from licensed UK wholesalers and delivered in 100% discreet packaging with next-day delivery options available.

Whether you're exploring what is the best antidepressant for weight loss or seeking dedicated weight management treatment, our clinical team will assess your individual circumstances, medical history, and treatment goals to recommend the most appropriate option. All consultations are conducted by GPhC-registered prescribers who follow NICE and MHRA guidelines for safe, effective prescribing.

Why Choose Cured Pharmacy

As a fully registered UK pharmacy (GPhC 9012511), we guarantee the lowest prices in the UK on genuine licensed medications. Our transparent pricing model means you'll never encounter surprise charges, and our clinical team is available by phone (+44 116 4646009) to answer questions about your treatment.

Every prescription medication requires online clinical assessment, but our streamlined process takes under 3 minutes to complete. Most patients receive prescriber approval within hours, with discreet delivery directly to your door anywhere in the UK.

Scientific References

1. Goldberg, J. F., & Burdick, K. E. (2016). Bupropion. In Cognitive Dysfunction in Bipolar Disorder (pp. 317-328). Cambridge University Press. https://doi.org/10.1017/CBO9781139915212
2. Serretti, A., & Mandelli, L. (2010). Antidepressants and body weight: a comprehensive review and meta-analysis. Journal of Clinical Psychiatry, 71(10), 1259-1272. https://doi.org/10.4088/JCP.09r05346blu
3. NHS. (2024). Antidepressants. NHS UK. https://www.nhs.uk/mental-health/talking-therapies-medicine-treatments/medicines-and-psychiatry/antidepressants/overview/
4. National Institute for Health and Care Excellence. (2022). Depression in adults: treatment and management. NICE guideline [NG222]. https://www.nice.org.uk/guidance/ng222
5. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
6. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038
7. Greenway, F. L., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet, 376(9741), 595-605. https://doi.org/10.1016/S0140-6736(10)60888-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication, particularly if you are currently taking antidepressants or have mental health conditions.